JMI Hospital Requisite Manufacturing Limited (DSE:JHRML)
Bangladesh · Delayed Price · Currency is BDT 43.70
+0.60 (1.39%)
At close: Feb 10, 2026
DSE:JHRML Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,574 | 1,671 | 1,870 | 1,852 | 1,802 | 1,731 | |
Revenue Growth (YoY) | -14.35% | -10.65% | 0.98% | 2.79% | 4.10% | 15.54% |
Cost of Revenue | 1,089 | 1,154 | 1,292 | 1,273 | 1,238 | 1,111 |
Gross Profit | 485.02 | 516.83 | 578.24 | 578.58 | 564.29 | 619.43 |
Selling, General & Admin | 218.49 | 149.41 | 152.34 | 145.16 | 134.28 | 127.45 |
Other Operating Expenses | 0.52 | 0.63 | 0.9 | 0.59 | 0.44 | 0.39 |
Operating Expenses | 219.01 | 150.05 | 153.23 | 145.75 | 134.73 | 127.85 |
Operating Income | 266.01 | 366.78 | 425.01 | 432.82 | 429.57 | 491.58 |
Interest Expense | -45.74 | -55.3 | -70.75 | -73.34 | -99.28 | -112.18 |
Interest & Investment Income | 1.02 | 2.23 | 8.54 | 14.21 | 7.02 | 0.94 |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | 0.51 | - | - | -0.14 |
Other Non Operating Income (Expenses) | 3.92 | 3.9 | 3.37 | 3.3 | 3.3 | 2.41 |
EBT Excluding Unusual Items | 225.26 | 317.65 | 366.68 | 376.99 | 340.61 | 382.62 |
Pretax Income | 225.26 | 317.65 | 366.68 | 376.99 | 340.61 | 382.62 |
Income Tax Expense | 80.4 | 84.53 | 73.57 | 74.7 | 15.59 | 157.61 |
Earnings From Continuing Operations | 144.86 | 233.13 | 293.11 | 302.29 | 325.02 | 225 |
Minority Interest in Earnings | 17.37 | 0.05 | 0.02 | - | - | - |
Net Income | 162.23 | 233.18 | 293.13 | 302.29 | 325.02 | 225 |
Net Income to Common | 162.23 | 233.18 | 293.13 | 302.29 | 325.02 | 225 |
Net Income Growth | -42.00% | -20.45% | -3.03% | -7.00% | 44.45% | 3.49% |
Shares Outstanding (Basic) | 125 | 125 | 125 | 125 | 100 | 90 |
Shares Outstanding (Diluted) | 125 | 125 | 125 | 125 | 100 | 90 |
Shares Change (YoY) | - | - | - | 25.35% | 11.07% | - |
EPS (Basic) | 1.29 | 1.86 | 2.34 | 2.41 | 3.25 | 2.50 |
EPS (Diluted) | 1.29 | 1.86 | 2.34 | 2.41 | 3.25 | 2.50 |
EPS Growth | -42.00% | -20.45% | -3.03% | -25.80% | 30.06% | 3.49% |
Free Cash Flow | 8.33 | -97.81 | 124.11 | 117.67 | 243.49 | 43.83 |
Free Cash Flow Per Share | 0.07 | -0.78 | 0.99 | 0.94 | 2.44 | 0.49 |
Dividend Per Share | 0.500 | 0.500 | 1.000 | 0.500 | 1.250 | - |
Dividend Growth | -50.00% | -50.00% | 100.00% | -60.00% | - | - |
Gross Margin | 30.81% | 30.93% | 30.92% | 31.24% | 31.32% | 35.79% |
Operating Margin | 16.90% | 21.95% | 22.73% | 23.37% | 23.84% | 28.40% |
Profit Margin | 10.30% | 13.96% | 15.67% | 16.32% | 18.04% | 13.00% |
Free Cash Flow Margin | 0.53% | -5.85% | 6.64% | 6.35% | 13.51% | 2.53% |
EBITDA | 402.4 | 507.06 | 570.48 | 587.04 | 594.37 | 673.16 |
EBITDA Margin | 25.56% | 30.35% | 30.50% | 31.70% | 32.99% | 38.89% |
D&A For EBITDA | 136.39 | 140.28 | 145.47 | 154.22 | 164.8 | 181.58 |
EBIT | 266.01 | 366.78 | 425.01 | 432.82 | 429.57 | 491.58 |
EBIT Margin | 16.90% | 21.95% | 22.73% | 23.37% | 23.84% | 28.40% |
Effective Tax Rate | 35.69% | 26.61% | 20.06% | 19.82% | 4.58% | 41.19% |
Advertising Expenses | - | 7.2 | 9.39 | 9.82 | 8.57 | 6.29 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.